Compare with Suven Life Sciences - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs SUVEN LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES SUVEN LIFE SCIENCES ALKEM LABORATORIES/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 22.4 -79.8 - View Chart
P/BV x 5.4 1.3 430.7% View Chart
Dividend Yield % 0.9 1.8 49.0%  

Financials

 ALKEM LABORATORIES   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
SUVEN LIFE SCIENCES
Mar-19
ALKEM LABORATORIES/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs2,720338 805.4%   
Low Rs1,660169 980.1%   
Sales per share (Unadj.) Rs697.952.1 1,338.7%  
Earnings per share (Unadj.) Rs96.16.8 1,407.2%  
Cash flow per share (Unadj.) Rs117.38.6 1,368.2%  
Dividends per share (Unadj.) Rs25.001.50 1,666.7%  
Dividend yield (eoy) %1.10.6 192.9%  
Book value per share (Unadj.) Rs515.265.3 789.2%  
Shares outstanding (eoy) m119.57127.28 93.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.9 64.5%   
Avg P/E ratio x22.837.1 61.4%  
P/CF ratio (eoy) x18.729.6 63.1%  
Price / Book Value ratio x4.33.9 109.5%  
Dividend payout %26.022.0 118.4%   
Avg Mkt Cap Rs m261,87932,272 811.5%   
No. of employees `00014.31.1 1,324.5%   
Total wages/salary Rs m15,055661 2,276.9%   
Avg. sales/employee Rs Th5,822.66,132.2 95.0%   
Avg. wages/employee Rs Th1,050.5611.1 171.9%   
Avg. net profit/employee Rs Th802.0803.5 99.8%   
INCOME DATA
Net Sales Rs m83,4446,635 1,257.6%  
Other income Rs m1,042242 430.1%   
Total revenues Rs m84,4866,877 1,228.5%   
Gross profit Rs m14,7341,604 918.5%  
Depreciation Rs m2,528221 1,141.6%   
Interest Rs m65138 1,725.7%   
Profit before tax Rs m12,5981,587 793.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105718 153.9%   
Profit after tax Rs m11,493869 1,321.9%  
Gross profit margin %17.724.2 73.0%  
Effective tax rate %8.845.2 19.4%   
Net profit margin %13.813.1 105.1%  
BALANCE SHEET DATA
Current assets Rs m54,9606,232 881.9%   
Current liabilities Rs m32,4331,490 2,176.6%   
Net working cap to sales %27.071.5 37.8%  
Current ratio x1.74.2 40.5%  
Inventory Days Days8086 92.1%  
Debtors Days Days7283 87.3%  
Net fixed assets Rs m32,7104,043 809.0%   
Share capital Rs m239127 187.8%   
"Free" reserves Rs m61,3688,183 750.0%   
Net worth Rs m61,6078,310 741.4%   
Long term debt Rs m1,59218 8,946.1%   
Total assets Rs m99,43310,389 957.1%  
Interest coverage x20.443.1 47.2%   
Debt to equity ratio x00 1,206.7%  
Sales to assets ratio x0.80.6 131.4%   
Return on assets %12.28.7 139.9%  
Return on equity %18.710.5 178.3%  
Return on capital %21.019.5 107.4%  
Exports to sales %19.10-   
Imports to sales %3.00-   
Exports (fob) Rs m15,917NA-   
Imports (cif) Rs m2,483NA-   
Fx inflow Rs m16,0615,622 285.7%   
Fx outflow Rs m2,4831,799 138.0%   
Net fx Rs m13,5783,822 355.2%   
CASH FLOW
From Operations Rs m5,851356 1,645.8%  
From Investments Rs m-7,414-279 2,661.0%  
From Financial Activity Rs m792-225 -351.6%  
Net Cashflow Rs m-731-148 493.3%  

Share Holding

Indian Promoters % 66.9 63.4 105.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 36.5 -  
Shareholders   68,381 37,287 183.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   PANACEA BIOTECH  BIOCON   FULFORD INDIA  JUBILANT PHARMOVA   AJANTA PHARMA  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

A Time Correction in the Nifty(Momentum Moves)

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Mar 5, 2021 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS